FirsthandHealth
medRxiv PreprintsInternational18 November 2026

Genome-resolved metagenomics reveals population-dependent gut microbiome responses to albendazole-ivermectin treatment

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Soil-transmitted helminth control relies on mass anthelmintic treatment, yet helminth-anthelmintic-microbiome interactions and their role on treatment response remain poorly understood. We characterised the microbiome, resistome, and functional profiles of 858 paired stool metagenomes from 429 children treated with albendazole or a fixed-dose albendazole-ivermectin co-formulation in the ALIVE clinical trial in Ethiopia and Mozambique. Baseline microbiome composition differed more by country than infection status and was not associated with albendazole efficacy or adverse events. Co-formulation
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.